Fast moving consumer goods (FMCG) company Dabur is planning to acquire more companies in the healthcare segment in India and could spend up to Rs 500 crore for the buyouts. The move follows the recent acquisition of Fem Care Pharma for over Rs 250 crore.
The company is also open to brand buyouts of up to Rs 200 crore. The company is looking for acquisitions of companies in the range of Rs 200-500 crore and brand acquisition of Rs 10-200 crore.
As with the past acquisition of Balsara — which added brands like Promise, Meswak, Odonil and Odopic to its oral care and home care portfolio — or the recent acquisition of Fem, which now gives it a presence in the Rs 2,500 crore mainstream skincare products market, Dabur is keen to diversify its traditional healthcare portfolio from ayurveda to include mainstream brands.